Serveur d'exploration sur les pandémies grippales - Exploration (Accueil)

Index « Keywords » - entrée « Toxicity »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Toxic shock syndrome toxin-1 < Toxicity < Toxicity Tests  Facettes :

List of bibliographic references indexed by Toxicity

Number of relevant bibliographic references: 71.
[20-40] [0 - 20][0 - 50][40-60]
Ident.Authors (with country if any)Title
002077 (2012) B. Rousseau [France] ; P. Loulergue [France] ; O. Mir [France] ; A. Krivine [France] ; S. Kotti [France] ; E. Viel [France] ; T. Simon [France] ; A. De Gramont [France] ; F. Goldwasser [France] ; O. Launay [France] ; C. Tournigand [France]Immunogenicity and safety of the influenza A HINIv 2009 vaccine in cancer patients treated with cytotoxic chemotherapy and/or targeted therapy: the VACANCE study
002078 (2012) A. Kostianovsky [France] ; P. Charles [France] ; J.-F. Alves [France] ; M. Goulet [France] ; C. Pagnoux [France] ; V. Le Guern [France] ; L. Mouthon [France] ; A. Krivine [France] ; P. Villiger [France, Suisse] ; O. Launay [France] ; L. Guillevin [France]Immunogenicity and safety of seasonal and 2009 pandemic A/H1N1 influenza vaccines for patients with autoimmune diseases: a prospective, monocentre trial on 199 patients
002112 (2012) Geneviève Durrieu [France] ; Aurore Palmaro [France] ; Laure Pourcel [France] ; Céline Caillet [France] ; Angeline Faucher [France] ; Alexis Jacquet [France] ; Shéhérazade Ouaret [France] ; Marie Christine Perault-Pochat [France] ; Carmen Kreft-Jais [France] ; Anne Castot [France] ; Maryse Lapeyre-Mestre [France] ; Jean-Louis Montastruc [France]First French Experience of ADR Reporting by Patients After a Mass Immunization Campaign with Influenza A (H1N1) Pandemic Vaccines: A Comparison of Reports Submitted by Patients and Healthcare Professionals
002136 (2012) Norio Sugaya [Japon] ; Shigeru Kohno [Japon] ; Toru Ishibashi [Japon] ; Toshihiro Wajima [Japon] ; Takao Takahashi [Japon]Efficacy, Safety, and Pharmacokinetics of Intravenous Peramivir in Children with 2009 Pandemic H1N1 Influenza A Virus Infection
002227 (2012) Greg L. Plosker [Nouvelle-Zélande]A/H5N1 Prepandemic Influenza Vaccine (Whole Virion, Vero Cell-Derived, Inactivated) [Vepacel®]
002796 (2011) G. V. Zuccotti ; E. Pariani [Italie] ; A. Scaramuzza ; L. Santoro ; E. Giani ; M. Macedoni ; A. Gazzarri ; G. Anselmi [Italie] ; A. Amendola [Italie] ; A. Zanetti [Italie]Long‐lasting immunogenicity and safety of a 2009 pandemic influenza A(H1N1) MF59‐adjuvanted vaccine when co‐administered with a 2009–2010 seasonal influenza vaccine in young patients with Type 1 diabetes mellitus
002967 (2011) Amel Chaabane [Tunisie] ; Karim Aouam [Tunisie] ; Nadia Ben Fredj [Tunisie] ; Adnen Toumi [Tunisie] ; Dorra Braham [Tunisie] ; Naceur A. Boughattas [Tunisie] ; Mohamed Chakroun [Tunisie]Les vaccins anti A(H1N1) en Tunisie : efficacité et tolérance
002998 (2011) Emanuele Amodio [Italie] ; Giovanna Anastasi [Italie] ; Maria Grazia Laura Marsala [Italie] ; Maria Valeria Torregrossa [Italie] ; Nino Romano [Italie] ; Alberto Firenze [Italie]Vaccination against the 2009 pandemic influenza A (H1N1) among healthcare workers in the major teaching hospital of Sicily (Italy)
002A63 (2011) Maja Folkenberg [Danemark] ; Torbjörn Callreus [Danemark] ; Henrik Svanström [Danemark] ; Palle Valentiner-Branth [Danemark] ; Anders Hviid [Danemark]Spontaneous reporting of adverse events following immunisation against pandemic influenza in Denmark November 2009-March 2010
002A81 (2011) YOUNG JUNE CHOE [Corée du Sud] ; Heeyeon Cho [Corée du Sud] ; SUNG NAM KIM [Corée du Sud] ; Geun-Ryang Bae [Corée du Sud] ; Jong-Koo Lee [Corée du Sud]Serious adverse events following receipt of trivalent inactivated influenza vaccine in Korea, 2003-2010
002A93 (2011) Cristina Cristiani [Italie] ; Marco Tuccori [Italie] ; Pasquale Pepe [Italie] ; Alessandro Sarteschi [Italie] ; Francesco Maddalo [Italie] ; Gianmarco Simonini [Italie] ; Paola Michi [Italie] ; Veronica Consigli [Italie] ; Matteo Fornai [Italie] ; Luca Antonioli [Italie] ; Corrado Blandizzi [Italie]Safety of MF-59 adjuvanted vaccine for pandemic influenza: Results of the vaccination campaign in an Italian health district
002A94 (2011) Xiao-Feng Liang [République populaire de Chine] ; LI LI [République populaire de Chine] ; Da-Wei Liu [République populaire de Chine] ; Ke-Li Li [République populaire de Chine] ; Wen-Di Wu [République populaire de Chine] ; Bao-Ping Zhu [République populaire de Chine] ; Hua-Qing Wang [République populaire de Chine] ; Hui-Ming Luo [République populaire de Chine] ; Ling-Sheng Cao [République populaire de Chine] ; Jing-Shan Zheng [République populaire de Chine] ; Da-Peng Yin [République populaire de Chine] ; LEI CAO [République populaire de Chine] ; Bing-Bing Wu [République populaire de Chine] ; Hong-Hong Bao [République populaire de Chine] ; Di-Sha Xu [République populaire de Chine] ; Wei-Zhong Yang [République populaire de Chine] ; YU WANG [République populaire de Chine]Safety of Influenza A (H1N1) Vaccine in Postmarketing Surveillance in China
002A95 (2011) Xavier Kurz [Royaume-Uni] ; François Domergue [Royaume-Uni] ; Jim Slattery [Royaume-Uni] ; Andrej Segec [Royaume-Uni] ; Agnieszka Szmigiel [Royaume-Uni] ; Ana Hidalgo-Simon [Royaume-Uni]Safety monitoring of Influenza A/H1N1 pandemic vaccines in EudraVigilance
002B01 (2011) Julia Stowe [Royaume-Uni] ; Nick Andrews [Royaume-Uni] ; Phil Bryan [Royaume-Uni] ; Suzie Seabroke [Royaume-Uni] ; Elizabeth Miller [Royaume-Uni]Risk of convulsions in children after monovalent H1 N1 (2009) and trivalent influenza vaccines: A database study
002B24 (2011) Alan Leeb [Australie] ; Dale Carcione [Australie] ; Peter C. Richmond [Australie] ; Peter Jacoby [Australie] ; Paul V. Effler [Australie]Reactogenicity of two 2010 trivalent inactivated influenza vaccine formulations in adults
002B40 (2011) Nick J. Andrews [Royaume-Uni] ; Woolf T. Walker [Royaume-Uni] ; Adam Finn [Royaume-Uni] ; Paul T. Heath [Royaume-Uni] ; Andrew C. Collinson [Royaume-Uni] ; Andrew J. Pollard [Royaume-Uni] ; Matthew D. Snape [Royaume-Uni] ; Saul N. Faust [Royaume-Uni] ; Pauline A. Waight [Royaume-Uni] ; Katja Hoschler [Royaume-Uni] ; Liz Sheasby [Royaume-Uni] ; Claire Waddington [Royaume-Uni] ; Simon Kerridge [Royaume-Uni] ; Jeremy Chalk [Royaume-Uni] ; Amanda Reiner [Royaume-Uni] ; Tessa John [Royaume-Uni] ; Margaret Fletcher [Royaume-Uni] ; Ruth Allen [Royaume-Uni] ; Natalie Fineman [Royaume-Uni] ; Su Wilkins [Royaume-Uni] ; Michelle Casey [Royaume-Uni] ; Louise Michaelis [Royaume-Uni] ; Clarissa Oeser [Royaume-Uni] ; Ifeanyichukwu Okike [Royaume-Uni] ; Shamez Ladhani [Royaume-Uni] ; Elizabeth Miller [Royaume-Uni]Predictors of immune response and reactogenicity to AS03B-adjuvanted split virion and non-adjuvanted whole virion H1N1 (2009) pandemic influenza vaccines
002B48 (2011) Yusuke Inoue [Japon] ; Kenji Matsui [Japon]Physicians' recommendations to their patients concerning a novel pandemic vaccine: a cross-sectional survey of the 2009 influenza A/H1N1 pandemic in Japan
002C21 (2011) Linda H Rmark [Pays-Bas] ; Florence Van Hunsel [Pays-Bas] ; Eelko Hak [Pays-Bas] ; Kees Van Grootheest [Pays-Bas]Monitoring the safety of influenza A (H1N1) vaccine using web-based intensive monitoring
002D85 (2011) Maribeth C. Lovegrove [États-Unis] ; Nadine Shehab [États-Unis] ; Craig M. Hales [États-Unis] ; Kathy Poneleit [États-Unis] ; Elizabeth Crane [États-Unis] ; Daniel S. Budnitz [États-Unis]Emergency Department Visits for Antiviral Adverse Events During the 2009 H1 N1 Influenza Pandemic
002D93 (2011) Ori Elkayam [Israël] ; Sharon Amir [Israël] ; Ella Mendelson [Israël] ; Mitchell Schwaber [Israël] ; Itamar Grotto [Israël] ; Jonathan Wollman [Israël] ; Uri Arad [Israël] ; Ayelet Brill [Israël] ; Daphna Paran [Israël] ; David Levartovsky [Israël] ; Irena Wigler [Israël] ; Dan Caspi [Israël] ; Michal Mandelboim [Israël]Efficacy and Safety of Vaccination Against Pandemic 2009 Influenza A (H1N1) Virus Among Patients With Rheumatic Diseases
002E31 (2011) Emilie Javelle [France] ; Benjamin Soulier ; Christian Brosset ; Solène Lorcy [France] ; Fabrice Simon [France]Delayed focal lipoatrophy after AS03-adjuvanted influenza A (H1N1) 2009 vaccine

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/PandemieGrippaleV1/Data/Main/Exploration
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdEn.i -k "Toxicity" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdEn.i  \
                -Sk "Toxicity" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    PandemieGrippaleV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    KwdEn.i
   |clé=    Toxicity
}}

Wicri

This area was generated with Dilib version V0.6.34.
Data generation: Wed Jun 10 11:04:28 2020. Site generation: Sun Mar 28 09:10:28 2021